This Amendment No. 2 amends and supplements the Schedule 13D originally filed with the Securities and Exchange Commission on August 26, 2014, as amended and supplemented on December 22, 2017 (this “Schedule 13D”) by Juniper NVM, LLC, a Delaware limited liability company (“Juniper NVM”), and certain other reporting persons, with respect to the common stock, par value $0.01 per share (“Common Stock”), of IMH Financial Corporation, a Delaware corporation (the “Issuer”). The filing of any amendment to this Schedule 13D shall not be construed to be an admission that a material change has occurred in the facts set forth in this Schedule 13D or that such amendment is required under Rule13d-2 of the Securities Exchange Act of 1934, as amended.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
Item 6 of this Schedule 13D is hereby amended to add the following information:
Amendment and Restatement of Certificate of Designation and Investors’ Rights Agreement
On February 9, 2018, in connection with the issuance by the Issuer to JPMorgan Chase Funding Inc. (“JPM Funding”) of SeriesB-3 Cumulative Convertible Preferred Stock (the “B-3 Preferred Shares”), the Issuer filed the Second Amended and Restated Certificate of Designation of SeriesB-1 Cumulative Convertible Preferred Stock, SeriesB-2 Cumulative Convertible Preferred Stock and SeriesB-3 Cumulative Convertible Preferred Stock (the “Restated Certificate”). The Restated Certificate, which governs the rights and preferences of the SeriesB-1 Cumulative Convertible Preferred Stock of the Issuer (the “B-1 Preferred Shares”) held by JCP Realty Partners, LLC (“JCP Realty Partners”) and Juniper NVM (together with JCP Realty Partners, the “Juniper Entities”), effected certain amendments primarily to establish the rights and preferences of theB-3 Preferred Shares. In addition, in connection with the issuance of theB-3 Preferred Shares, the Issuer, JPM Funding and the Juniper Entities entered into an Amended and Restated Investors’ Rights Agreement (the “Restated Rights Agreement”), primarily to include the Common Stock issuable upon conversion of theB-3 Preferred Shares in the registration rights thereunder, which are applicable to the Common Stock issuable upon conversion of theB-1 Preferred Shares and the Issuer’s SeriesB-2 Cumulative Convertible Preferred Stock (the “B-2 Preferred Shares”, and together with theB-1 Preferred Shares and theB-3 Preferred Shares, the “Series B Preferred Stock”).
Investment Agreement
On April 11, 2017, the Issuer, JPM Funding and the Juniper Entities entered into an Investment Agreement (the “Series B Investment Agreement”). On February 9, 2018, the Series B Investment Agreement was amended and restated in its entirety in connection with the issuance of theB-3 Preferred Shares (the “Restated Investment Agreement”). Pursuant to the Restated Investment Agreement, the Issuer agreed to take all commercially reasonable actions as are reasonably necessary for the Issuer to be eligible to rely on the exemption (the “Real Estate Exemption”) provided by Section 3(c)(5)(C) of the Investment Company Act of 1940, as amended (the “Investment Company Act”) and to remain eligible to rely on such exemption at all times thereafter. The Issuer agreed not to take any action, the result of which would reasonably be expected to cause the Issuer to become ineligible for the Real Estate Exemption without the prior written consent of JPM Funding and the Juniper Entities. Furthermore, pursuant to the Restated Investment Agreement, until such time as JPM Funding determines in its sole discretion that JPM Funding could not be deemed to be an affiliate of the Issuer for purposes of the Bank Holding Company Act of 1956, as amended (such act, the “BHCA” and such an affiliate, a “BHCA Affiliate”), the Issuer shall not, and shall not allow its BHCA Affiliates to, engage in proprietary trading and certain other activities prohibited under Section 13 of the BHCA and the rules and regulations adopted thereunder, as amended. In the event that the Issuer violates any of the foregoing covenants, and that violation is not cured within 60 days of the violation, JPM Funding has (and if JPM Funding exercises, the Juniper Entities have) the right to demand that the Issuer purchase all of their shares of Series B Preferred Stock at the Required Redemption Price as set forth in the Restated Certificate.
The Restated Investment Agreement also provides that in the event of modification of the parity between theB-1 Preferred Shares andB-2 Preferred Shares that existed pursuant to the terms of the Certificate of Designation of the Issuer’s Series B Cumulative Convertible Preferred Stock in effect as of April 10, 2017 in a manner that is adverse to either Juniper Entity or JPM Funding, then: (a) the other parties to the Restated Investment Agreement shall reasonably cooperate with the adversely affected party to attempt to restore or otherwise accomplish such parity; and (b) if, after reasonably cooperating, the parties are unable to restore or otherwise accomplish such parity, then the Issuer shall indemnify such adversely affected party for the damages and other losses (including diminution in value) suffered by such party from such absence of parity, and such indemnification shall be such party’s sole remedy with respect to such inability to restore or otherwise accomplish parity unless the Issuer is unable to restore or otherwise accomplish such parity in full.